Published in Eur Arch Psychiatry Clin Neurosci on November 15, 2005
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46
Trace amine-associated receptor 1 as a monoaminergic modulator in brain. Biochem Pharmacol (2009) 1.27
A pilot multivariate parallel ICA study to investigate differential linkage between neural networks and genetic profiles in schizophrenia. Neuroimage (2009) 1.00
Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density. Schizophr Bull (2012) 0.97
The neurobiology and treatment of first-episode schizophrenia. Mol Psychiatry (2014) 0.93
Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait. Psychopharmacology (Berl) (2006) 0.92
Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association. J Neurosci Res (2008) 0.89
Yoga lessons for consciousness research: a paralimbic network balancing brain resource allocation. Front Psychol (2011) 0.82
Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients. Eur Arch Psychiatry Clin Neurosci (2011) 0.81
Abnormal striatal dopamine transmission in schizophrenia. Curr Med Chem (2013) 0.81
The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine. Neuroscience (2011) 0.80
Fine-mapping reveals novel alternative splicing of the dopamine transporter. Am J Med Genet B Neuropsychiatr Genet (2010) 0.80
Making sense: Dopamine activates conscious self-monitoring through medial prefrontal cortex. Hum Brain Mapp (2015) 0.80
Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis. Schizophr Bull (2011) 0.79
How have developments in molecular imaging techniques furthered schizophrenia research? Imaging Med (2009) 0.77
Obstetric complications and neurological abnormalities in neuroleptic-naive psychotic patients. Eur Arch Psychiatry Clin Neurosci (2006) 0.76
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
A functional neuroanatomy of hallucinations in schizophrenia. Nature (1995) 3.78
Abnormal monitoring of inner speech: a physiological basis for auditory hallucinations. Lancet (1995) 3.74
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A (1997) 3.00
Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry (2000) 2.93
Pathways that make voices: white matter changes in auditory hallucinations. Arch Gen Psychiatry (2004) 2.57
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry (1998) 2.30
Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry (1999) 2.27
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol (2001) 2.12
Temporal course of auditory hallucinations. Br J Psychiatry (2004) 1.95
The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci (1995) 1.89
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett (2000) 1.65
Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology (1997) 1.50
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med (2000) 1.48
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet (1995) 1.37
Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci U S A (1994) 1.30
The neural correlates of inner speech and auditory verbal imagery in schizophrenia: relationship to auditory verbal hallucinations. Br J Psychiatry (1996) 1.24
Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol Psychiatry (1999) 1.21
Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res (2003) 1.15
Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. J Med Chem (1997) 1.14
The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev (2003) 1.08
Engagement of brain areas implicated in processing inner speech in people with auditory hallucinations. Br J Psychiatry (2003) 1.08
Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr Res (1997) 1.04
Functional anatomy of auditory verbal imagery in schizophrenic patients with auditory hallucinations. Am J Psychiatry (2000) 1.03
Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med (2000) 1.01
Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. Am J Psychiatry (2000) 0.97
Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res (2001) 0.96
Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats. Eur J Nucl Med (1998) 0.92
Cognitive neuropsychiatry: towards a scientific psychopathology. Nat Rev Neurosci (2001) 0.91
The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease. Nucl Med Commun (2001) 0.91
Verbal self-monitoring and auditory hallucinations in schizophrenia. Lancet (1999) 0.88
Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1. J Nucl Med (2001) 0.88
Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1. Schizophr Res (2003) 0.86
Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry (2004) 0.85
Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Biol Psychiatry (2000) 0.84
Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters. J Nucl Med (1998) 0.84
Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. Schizophr Res (2001) 0.81
The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. J Psychopharmacol (2005) 0.79
Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons. J Nucl Med (1999) 0.78
Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents. J Med Chem (1998) 0.78
Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent. Nucl Med Biol (2001) 0.75
LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry (2007) 3.49
Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg (2009) 2.58
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 2.44
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
[A new method for early detection of neurotoxic diseases (exemplified by pyrethroid poisoning)]. Gesundheitswesen (1995) 2.12
The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry (2010) 2.03
Adaptation of oral streptococci to low pH. Adv Microb Physiol (2000) 1.88
The Xanthomonas Hrp type III system secretes proteins from plant and mammalian bacterial pathogens. Proc Natl Acad Sci U S A (1999) 1.71
Genetics of acid adaptation in oral streptococci. Crit Rev Oral Biol Med (2001) 1.71
Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry (2004) 1.63
Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment. Brain (2006) 1.62
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry (2004) 1.60
A di-acidic (DXE) code directs concentration of cargo during export from the endoplasmic reticulum. J Biol Chem (1999) 1.56
Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry (2000) 1.53
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Mol Psychiatry (2004) 1.53
Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: preliminary experience. Ann Surg Oncol (2010) 1.51
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. J Nucl Med (2000) 1.50
hpaA mutants of Xanthomonas campestris pv. vesicatoria are affected in pathogenicity but retain the ability to induce host-specific hypersensitive reaction. Mol Microbiol (1998) 1.50
Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry (2002) 1.49
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med (2000) 1.48
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Reappraisal of quantitative esophageal scintigraphy by optimizing results with ROC analyses. J Nucl Med (1996) 1.41
Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry (2011) 1.40
[Core symptoms of depression. Effectiveness of antidepressant therapy]. Nervenarzt (2009) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Prolonged confusional state following electroconvulsive therapy--diagnostic clues from serial electroencephalography. Pharmacopsychiatry (2005) 1.39
D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. J Psychopharmacol (2000) 1.39
Advanced imaging of head and neck tumors. Acta Radiol (1995) 1.38
Guidelines for standard and diuretic renography in children. Eur J Nucl Med (2001) 1.37
A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med (1990) 1.32
Early postnatal development of rat brain: in vivo diffusion tensor imaging. J Neurosci Res (2008) 1.31
Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry (2004) 1.31
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry (2008) 1.28
Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord (2004) 1.22
Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand (2007) 1.22
Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study. Schizophr Res (2008) 1.22
Prefrontal direct current stimulation modulates resting EEG and event-related potentials in healthy subjects: a standardized low resolution tomography (sLORETA) study. Neuroimage (2010) 1.22
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry (2008) 1.20
The role of dopamine for the pathophysiology of schizophrenia. Int Rev Psychiatry (2007) 1.18
Normative volumetric data of the developing hippocampus in children based on magnetic resonance imaging. Epilepsia (1999) 1.14
Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res (2008) 1.13
The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) (2000) 1.13
Jaundice in urinary tract infection in infancy. Am J Dis Child (1969) 1.13
Behavioural and glial changes in old rats following environmental enrichment. Behav Brain Res (1999) 1.12
[Psychometric evaluation of the German version of the Barratt Impulsiveness Scale]. Nervenarzt (2008) 1.12
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Assessing DTI data quality using bootstrap analysis. Magn Reson Med (2004) 1.10
Guidelines for 99mTc-DMSA scintigraphy in children. Eur J Nucl Med (2001) 1.08
Stable co-expression of calcium channel alpha 1, beta and alpha 2/delta subunits in a somatic cell line. J Physiol (1993) 1.08
Matrix valency regulates integrin-mediated lymphoid adhesion via Syk kinase. J Cell Biol (1999) 1.08
The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci (1998) 1.08
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J Neural Transm (Vienna) (2002) 1.07
Association of anger-related traits with SNPs in the TPH gene. Mol Psychiatry (2002) 1.06
Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging (2008) 1.05
Neurochemical substrates and neuroanatomical generators of the event-related P300. Neuropsychobiology (1999) 1.04
MRI in tracheal stenosis by innominate artery in children. Pediatr Radiol (1991) 1.04
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry (2006) 1.04
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry Suppl (2007) 1.02
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging (2002) 1.01
Stable and functional expression of the calcium channel alpha 1 subunit from smooth muscle in somatic cell lines. EMBO J (1992) 1.00
MRI and radiographic findings in Currarino's triad. Pediatr Radiol (1996) 1.00
Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00
Infections with various types of organisms stimulate transcription from a short promoter fragment of the potato gst1 gene. Mol Plant Microbe Interact (1996) 0.98
Patterns of nurse-physician communication and agreement on the plan of care. Qual Saf Health Care (2010) 0.98
Cerebral differences in explicit and implicit emotional processing--an fMRI study. Neuropsychobiology (2007) 0.98
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification. Eur Psychiatry (2011) 0.97
Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype. Am J Med Genet B Neuropsychiatr Genet (2012) 0.97
Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity. J Neural Transm (Vienna) (2003) 0.97
Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease. Neurobiol Aging (2006) 0.97
Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97
Postural imbalance and falls in PSP correlate with functional pathology of the thalamus. Neurology (2011) 0.96
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Pharmacopsychiatry (2002) 0.96
Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96
Time resolving ionization monitor for microsecond radiation impulses. Phys Med Biol (1998) 0.95
Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett (2007) 0.95
Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography. Eur J Nucl Med (1997) 0.95
The carpal ligaments in MR arthrography of the wrist: correlation with standard MRI and wrist arthroscopy. J Magn Reson Imaging (1999) 0.95
FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis. J Neuropsychiatry Clin Neurosci (2000) 0.95
Neuroimaging genetics: new perspectives in research on major depression? Acta Psychiatr Scand (2008) 0.94
Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet (2003) 0.94
The librarian as a partner in nursing education. Bull Med Libr Assoc (1995) 0.93
Echocardiographic findings in patients with proved pulmonary embolism. Am Heart J (1986) 0.93